Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Conformis Inc CS (CFMS)

Conformis Inc CS (CFMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 154,498
  • Shares Outstanding, K 182,428
  • Annual Sales, $ 68,760 K
  • Annual Income, $ -24,290 K
  • 60-Month Beta 1.26
  • Price/Sales 2.20
  • Price/Cash Flow N/A
  • Price/Book 7.02
Trade CFMS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/05/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.08
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7950 +6.53%
on 04/13/21
1.1600 -26.99%
on 03/19/21
-0.2531 (-23.01%)
since 03/16/21
3-Month
0.7950 +6.53%
on 04/13/21
1.4900 -43.16%
on 02/09/21
-0.3731 (-30.58%)
since 01/15/21
52-Week
0.6015 +40.80%
on 11/02/20
1.4900 -43.16%
on 02/09/21
+0.2174 (+34.54%)
since 04/16/20

Most Recent Stories

More News
Globus Medical (GMED) Simplifies Spine Surgery With CREO ONE

Globus Medical's (GMED) latest development to robotically navigated spine surgery will enable surgeons to maintain the navigational accuracy without performing traditional pedicle preparation.

GMED : 69.75 (+0.14%)
CFMS : 0.8469 (+2.16%)
ITGR : 93.05 (-0.61%)
CMD : 86.74 (+0.51%)
Walgreens (WBA) Extends COVID-19 Vaccination to 49 States

Walgreens (WBA) continues to expand access to COVID-19 vaccination in medically underserved communities and has surpassed 11 million administrations to date.

WBA : 53.30 (-0.78%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
UBER : 60.35 (-0.64%)
Here's Why You Should Hold on to STERIS (STE) Stock Now

Investors are optimistic about STERIS (STE) owing to strong segmental performance amid the pandemic and huge growth potential in healthcare and pharmaceutical industries.

STE : 208.14 (+0.69%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
ASXC : 1.7500 (-6.91%)
Abbott (ABT) Gets Europe Nod for TriClip G4 to Treat TR

Per Abbott's (ABT) TRILUMINATE CE Mark study, the latest version shows sustained symptomatic improvement, reduction in the severity of TR and improvement in functional status.

ABT : 124.35 (+0.33%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
ASXC : 1.7500 (-6.91%)
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021

Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021 at approximately 4:00 p.m. Eastern...

CFMS : 0.8469 (+2.16%)
Quest Diagnostics (DGX) Rides on Test Sales Amid Volume Woe

Quest Diagnostics (DGX) enters into an agreement with the CDC to provide genomic sequencing to identify new mutations in and patterns of transmission of SARS-CoV-2.

DGX : 130.11 (+0.74%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
ASXC : 1.7500 (-6.91%)
Orthofix (OFIX) Wins FDA Clearance for CONSTRUX Mini Ti System

Orthofix's (OFIX) CONSTRUX Mini Ti Spacer System, designed with nanoscale surface is the first 3D-printed titanium interbody, was launched to enhance ACDF procedures.

OFIX : 44.17 (+1.24%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
ASXC : 1.7500 (-6.91%)
Here's Why You Should Retain Integra LifeSciences (IART) Stock

Investors are optimistic about Integra LifeSciences (IART) stock, owing to its strong international business growth and focus on portfolio optimization.

IART : 72.25 (+1.83%)
CFMS : 0.8469 (+2.16%)
PEN : 287.39 (+0.37%)
CMD : 86.74 (+0.51%)
Varian Medical (VAR) Hits 52-Week High: What's Driving It?

Varian Medical (VAR) is optimistic about its prospective acquisitions and strength in Proton Therapy segment.

ELMD : 10.22 (+2.00%)
VAR : 177.07 (-0.02%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
Badanie kliniczne: CaIkowita endoprotezoplastyka stawu kolanowego z uzyciem implantu indywidualnie przygotowanego dla danego pacjenta z zastosowaniem technologii Conformis jest bardziej opIacalna niz stosowanie wiodacych implantow typowych

Niezalezny retrospektywny przeglad danych zabiegowych z lat 2016-2019 przeprowadzony przez badaczy z Uniwersytetu Waszyngtonskiego pokazuje, ze implanty Conformis iTotal(R) przeznaczone do caIkowitej endoprotezoplastyki...

CFMS : 0.8469 (+2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company's iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The...

See More

Key Turning Points

3rd Resistance Point 0.9176
2nd Resistance Point 0.8887
1st Resistance Point 0.8678
Last Price 0.8469
1st Support Level 0.8180
2nd Support Level 0.7891
3rd Support Level 0.7682

See More

52-Week High 1.4900
Fibonacci 61.8% 1.1506
Fibonacci 50% 1.0458
Fibonacci 38.2% 0.9409
Last Price 0.8469
52-Week Low 0.6015

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar